These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21272627)

  • 1. Evaluation of a crystalline nanosuspension: polymorphism, process induced transformation and in vivo studies.
    Sharma P; Zujovic ZD; Bowmaker GA; Marshall AJ; Denny WA; Garg S
    Int J Pharm; 2011 Apr; 408(1-2):138-51. PubMed ID: 21272627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and in vitro/in vivo evaluation of revaprazan hydrochloride nanosuspension.
    Li W; Yang Y; Tian Y; Xu X; Chen Y; Mu L; Zhang Y; Fang L
    Int J Pharm; 2011 Apr; 408(1-2):157-62. PubMed ID: 21295124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery.
    Ganta S; Paxton JW; Baguley BC; Garg S
    Int J Pharm; 2009 Feb; 367(1-2):179-86. PubMed ID: 18848873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting.
    Aji Alex MR; Chacko AJ; Jose S; Souto EB
    Eur J Pharm Sci; 2011 Jan; 42(1-2):11-8. PubMed ID: 20971188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of a chemically stable quercetin formulation using nanosuspension technology.
    Gao L; Liu G; Wang X; Liu F; Xu Y; Ma J
    Int J Pharm; 2011 Feb; 404(1-2):231-7. PubMed ID: 21093559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat.
    Rabinow B; Kipp J; Papadopoulos P; Wong J; Glosson J; Gass J; Sun CS; Wielgos T; White R; Cook C; Barker K; Wood K
    Int J Pharm; 2007 Jul; 339(1-2):251-60. PubMed ID: 17398045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of wet milling process on the solid state of indomethacin and simvastatin.
    Sharma P; Denny WA; Garg S
    Int J Pharm; 2009 Oct; 380(1-2):40-8. PubMed ID: 19576976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of pluronic nanosuspensions loading a novel insoluble anticancer drug both in vitro and in vivo.
    Tang XJ; Fu YH; Meng QH; Li LM; Ying XY; Han M; He QJ; Yang B; Zeng S; Hu YZ; Sheng XX; Gao JQ
    Int J Pharm; 2013 Nov; 456(1):243-50. PubMed ID: 23928148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of spray granulation for conversion of a nanosuspension into a dry powder form.
    Bose S; Schenck D; Ghosh I; Hollywood A; Maulit E; Ruegger C
    Eur J Pharm Sci; 2012 Aug; 47(1):35-43. PubMed ID: 22565066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs.
    De Smet L; Saerens L; De Beer T; Carleer R; Adriaensens P; Van Bocxlaer J; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2014 May; 87(1):107-13. PubMed ID: 24388913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil.
    Sharma P; Ganta S; Denny WA; Garg S
    Int J Pharm; 2009 Feb; 367(1-2):187-94. PubMed ID: 18930127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of novel itraconazole-loaded intravenous nanoparticles.
    Chen W; Gu B; Wang H; Pan J; Lu W; Hou H
    Int J Pharm; 2008 Oct; 362(1-2):133-40. PubMed ID: 18585448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding a relaxation behavior in a nanoparticle suspension for drug delivery applications.
    Deng Z; Xu S; Li S
    Int J Pharm; 2008 Mar; 351(1-2):236-43. PubMed ID: 18093763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on pharmacokinetics and tissue distribution of oridonin nanosuspensions.
    Gao L; Zhang D; Chen M; Duan C; Dai W; Jia L; Zhao W
    Int J Pharm; 2008 May; 355(1-2):321-7. PubMed ID: 18242896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanosuspension for parenteral delivery of a p-terphenyl derivative: preparation, characteristics and pharmacokinetic studies.
    Tian X; Li H; Zhang D; Liu G; Jia L; Zheng D; Shen J; Shen Y; Zhang Q
    Colloids Surf B Biointerfaces; 2013 Aug; 108():29-33. PubMed ID: 23528604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of carboplatin biodegradable polymeric nanoparticles.
    Nanjwade BK; Singh J; Parikh KA; Manvi FV
    Int J Pharm; 2010 Jan; 385(1-2):176-80. PubMed ID: 19854254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
    Jadhav GS; Vavia PR
    Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity.
    Kim TH; Jiang HH; Youn YS; Park CW; Tak KK; Lee S; Kim H; Jon S; Chen X; Lee KC
    Int J Pharm; 2011 Jan; 403(1-2):285-91. PubMed ID: 21035530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.